TP53 and neoplasm: Notably, subclonal expression, nonsense mutations, and low-proliferative tumor cells can result in focal weak positivity in P53 IHC, potentially misleading pathologists and leading to misinterpretation, as approximately 5% of p53 mutation subtype patients may not exhibit detectable P53 IHC mutations (Köbel et al., 2019).